Moreover, hepatic-specific Rubicon knockout mice were resistant to HFD-induced hepatic steatosis and injury, suggesting that Rubicon may be a suitable therapeutic target for NAFLD [38]. The gene discussed is RUBCN; the disease is metabolic dysfunction-associated steatotic liver disease.